Term
|
Definition
Anti-metabolite (hypoxanthine mimicker) that inhibits PRPP aminotransferase
-inhibit de novo purine synth
*catalyzed by HGPRT
Works by (-) feedback of PRPP amidotransferase
*metabolized by xanthine oxidase (use allopurinol) |
|
|
Term
|
Definition
Anti-metabolite (inhibits DHFR) thus inhibit purine and thymidylate synthesis
-Gets polyglutamated to activate (^ anti-thym synth and keeps it in the cell)
*Leucovorin used to rescue cells
Contra: Extra water mass |
|
|
Term
|
Definition
Anti-metabolite (hypoxanthine mimicker) that inhibits PRPP aminotransferase
-inhibit de novo purine synth
*catalyzed by HGPRT
incorporated into DNA and RNA
*Tumor lysis syndrome
-xanthine oxidase (Tx: allopurinol) |
|
|
Term
|
Definition
Purine anti-metabolite
-phosphorylated intracellularly to triphos, incorporated into DNA and causes chain termination
*activates apoptosis
Tx: CLL |
|
|
Term
|
Definition
Pyrimidine antimetabolite
-has to be phorsphorylated
-in the presence of THF binds to thymidylate synthase and traps enzyme in intermediate step
*enhances toxicity with leucovorin
*radiation sensitizer |
|
|
Term
|
Definition
Pyrimidine anti-metabolite used in AML
-must be phosphorylated
-Incorporated into DNA and inhibits DNA polymerase (only effective during S-phase)
|
|
|
Term
|
Definition
Pyrimidine anti-metabolite
-phosphorylated
-Inhibits ribonucleotide reductase, causing depletion of dNTP pool
-Incorporated into DNA causing strand termination
*Potent radiosensitizer and shouldn't be used with radiotherapy |
|
|
Term
|
Definition
Antimetabolite
-Active by itself
-Inhibits ribonucleotide reductase, depleting dNTP, arresting cells @ G1/S (more sensitive to radiation) |
|
|
Term
|
Definition
Antibiotic anti-cancer
intercalates into G-C rich regions, can inhibit DNA synth
*produces free-radicals |
|
|
Term
|
Definition
Antibiotic Anti-Cancer
G-C rich regions, depression DNA, RNA, & protein synth
*Lowers Ca2+ in pts with hypercalcemia |
|
|
Term
|
Definition
Anthracycline antibiotic Anti-Cancer
Stabilizes topoisomerase II & generates free radicals (^ apoptosis)
*can turn pee bright red
Contra: Cardiac dx (has cardiac toxicity) |
|
|
Term
|
Definition
Anthracycline Antibiotic anti-Cancer
Stabilizes topoisomerase II & generates free radicals (^ apoptosis)
*dont use with impaired liver
|
|
|
Term
|
Definition
Antracycline derivative antibiotic Anti-Cancer
-inhibit topoisomerase II
*less nausea and vomiting than doxo daunorubicin |
|
|
Term
|
Definition
Antracycline derivative antibiotic Anti-Cancer
-inhibit topoisomerase II (limited free radical production)
*less nausea and vomiting than doxo daunorubicin |
|
|
Term
|
Definition
Antibiotic Anti-Cancer
-DNA binding and DNA scission (binds Fe++)
**may lead to pulmonary fibrosis (due to low bleomycin hydrolase in lung and skin..hyperpigmentation) |
|
|
Term
|
Definition
Antibiotic anti-CA
-Reduced in hypoxic environments (produces free radicals)
-Causes cross-links |
|
|
Term
|
Definition
Anti-mitotic anti-CA
-Bind B-tubulin and block polymerization with a-tubulin (causing depolymerization)
|
|
|
Term
|
Definition
Vinca-alkaloid treats teste tumors causing neutropenia |
|
|
Term
|
Definition
Tx ped leukemias and breast CA causing *Peripheral Neurotoxicity |
|
|
Term
|
Definition
Anti-mitotic anti-CA
-promotes polymerization of microtubules (forms abnormal structures)- G2/M
*^ expression of P-glycoprotein=resistance |
|
|
Term
|
Definition
Anti-mitotic anti-CA
-promotes polymerization of microtubules (forms abnormal structures)- G2/M
*^ expression of P-glycoprotein=resistance |
|
|
Term
|
Definition
Anti-Cancer
*bind and trap DNA topoisomerase II |
|
|
Term
|
Definition
Anti-Cancer
*bind and trap DNA topoisomerase II |
|
|
Term
|
Definition
Anti-Cancer
Topoisomerase I inhibitors
*causes double stranded break when rep fork catches it
Renal Clearance |
|
|
Term
|
Definition
Anti-Cancer
Topoisomerase I inhibitors
*causes double stranded break when rep fork catches it
Prodrug |
|
|
Term
|
Definition
*Some lymphoid tumors lack ability to synth L-asparagine
*can cause allergic rxn |
|
|
Term
|
Definition
Nitrogen Mustard (alkylating agent)
-Forms cross-links |
|
|
Term
|
Definition
Nitrogen Mustard (alkylating agent)
-Forms cross-links
*requires metabolic activation in liver
Sfx: hemmorhagic cystitis (by acrolein)
*Use Mesna |
|
|
Term
|
Definition
Nitrogen Mustard (alkylating agent)
-Forms cross-links
*designed derivative |
|
|
Term
|
Definition
Orally active Nitrogen Mustard (alkylating agent)
-Forms cross-links
Sfx: GI upset and hepatotoxicity |
|
|
Term
|
Definition
Orally administered Alkyl sulfunate |
|
|
Term
|
Definition
Nitrosurea
anti-CA used for brain tumors (lipophilic)
*can cause severe delayed myelosuppression |
|
|
Term
|
Definition
Nitrosurea
anti-CA used for brain tumors (lipophilic)
*can cause severe delayed myelosuppression |
|
|
Term
|
Definition
Nitrosurea
anti-CA used for brain tumors (lipophilic)
*can cause severe delayed myelosuppression
and delayed renal failure in children |
|
|
Term
|
Definition
Nitrosurea that methylates @ O-6 (not N7)
-monofxnal, can be carcinogenic |
|
|
Term
|
Definition
Anticancer, requires activation in liver makes MTIC kills cells in all phases of cell cycle |
|
|
Term
|
Definition
AntiCancer
causes DNA methylation, plasma t1/2= 7 mins
*monofxnal=highly carcinogenic, can cause infertility |
|
|
Term
|
Definition
Platinum complex
-undergo sequential aquation, causes intrastrand adducts
Sfx:Ototoxicity |
|
|
Term
|
Definition
Platinum complex
-undergo sequential aquation, causes intrastrand adducts
Sfx:Ototoxicity |
|
|
Term
|
Definition
Steroidal antiestrogen, binds E2R causing downregulation
2nd line tx |
|
|
Term
|
Definition
|
|
Term
|
Definition
GnRH superagonist- inhibits gonadotropin release |
|
|
Term
|
Definition
GnRH superagonist- inhibits gonadotropin release |
|
|
Term
|
Definition
Non-steroidal androgen receptor blocker |
|
|
Term
|
Definition
|
|
Term
|
Definition
all-trans retinoic acid
APML |
|
|
Term
|
Definition
Tyrosine Kinase inhib
CML (Bcr-Abl) |
|
|
Term
|
Definition
EGFR Tyrosine Kinase inhib
NSCLC |
|
|
Term
|
Definition
EGFR Tyrosine Kinase inhib
SCLC |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Competitive antag at EGFR |
|
|
Term
|
Definition
Binds CD20 on B-cells, causing death |
|
|
Term
|
Definition
|
|
Term
|
Definition
prevents degradation of pro-apoptotic factors |
|
|